Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cylite’s HP-OCT system provides high-speed, volumetric OCT imaging for both anterior and posterior segments of the eye. It enables accurate corneal topography/tomography and supports advanced applications like contact lens fitting. The technology has been recognized with major engineering awards in Australia. Clinical adoption began by at least early 2024.
The PreMO software addition allows clinicians to predict myopia onset/progression using axial length data against predictive growth curves.
No drug or therapeutic clinical trials; product-focused on diagnostic devices.
Acquired by Alcon in January 2025 to be integrated into their global eyecare portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cylite.